Remibrutinib, an oral Bruton tyrosine kinase inhibitor (BTKi), was approved for the treatment of chronic spontaneous ...

The global prevalence of heart failure (HF) more than doubled in recent decades, from around 24 million cases in 1990 to 56 million in 2023, according to new estimates from the Global Burden of ...

Spirulina shows small benefits for blood pressure, lipids, and weight, but experts say the evidence remains too limited for ...

Children with spinal muscular atrophy treated within 3 weeks of birth are more likely to meet mobility milestones and have ...